Sexual activity and cardiovascular disease: A scientific statement from the American Heart Association

Circulation

Volumn 125, Issue 8, 2012, Pages 1058-1072

  Levine, Glenn N ^a   Steinke, Elaine E ^a   Bakaeen, Faisal G ^a   Bozkurt, Biykem ^a   Cheitlin, Melvin D ^a   Conti, Jamie Beth ^a   Foster, Elyse ^a   Jaarsma, Tiny ^a   Kloner, Robert A ^a   Lange, Richard A ^a   Lindau, Stacy Tessler ^a   Maron, Barry J ^a   Moser, Debra K ^a   Ohman, E Magnus ^a   Seftel, Allen D ^a   Stewart, William J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARGININE; EPLERENONE; ESTROGEN; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; NEBIVOLOL; NITRATE; PHOSPHODIESTERASE V INHIBITOR; PROGESTERONE; SILDENAFIL; SPIRONOLACTONE; TADALAFIL; VARDENAFIL; YOHIMBINE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL CLASSIFICATION; CONGENITAL HEART DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DRUG ANTAGONISM; DRUG HALF LIFE; DRUG INDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPAREUNIA; ERECTILE DYSFUNCTION; ESTROGEN THERAPY; GYNECOMASTIA; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LIBIDO DISORDER; MARITAL THERAPY; MEDICAL SOCIETY; OPEN HEART SURGERY; PACEMAKER; PATIENT COUNSELING; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SUDDEN DEATH; SYSTOLIC HEART FAILURE; VAGINA PAIN; VALVULAR HEART DISEASE; VASODILATATION;

AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; HUMANS; PRACTICE GUIDELINES AS TOPIC; SEXUAL BEHAVIOR; UNITED STATES;

EID: 84857995361     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3182447787     Document Type: Review

References (148)

1. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762-774. (Pubitemid 47295643)
2. Kriston L, Gunzler C, Agyemang A, Bengel J, Berner MM; SPARK Study Group. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation: findings of the SPARK project in 493 patients. J Sex Med. 2010;7:2044 -2055.
3. Friedman S. Cardiac disease, anxiety, and sexual functioning. Am J Cardiol. 2000;86:46F-50F.
4. Debusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel SE, Kostis JB, Kloner RA, Lakin M, Meston CM, Mittleman M, Muller JE, Padma-Nathan H, Rosen RC, Stein RA, Zusman R. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol. 2000;86:175-181. (Pubitemid 30410727)
5. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:313-321. (Pubitemid 40978596)
6. Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol. 2005;45:1334 -1340.
7. Graham TP Jr, Driscoll DJ, Gersony WM, Newburger JW, Rocchini A, Towbin JA. Task Force 2: congenital heart disease. J Am Coll Cardiol. 2005;45:1326 -1333.
8. Zipes DP, Ackerman MJ, Estes NA 3rd, Grant AO, Myerburg RJ, Van Hare G. Task Force 7: arrhythmias. J Am Coll Cardiol. 2005;45:1354-1363. (Pubitemid 40523167)
9. Thompson PD, Balady GJ, Chaitman BR, Clark LT, Levine BD, Myerburg RJ. Task Force 6: coronary artery disease. J Am Coll Cardiol. 2005;45:1348 -1353.
10. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005;45:1340 -1345.
11. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carrè F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:1422-1445.
12. Heidbuchel H, Corrado D, Biffi A Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13:676-686. (Pubitemid 44462668)
13. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, Hoffmann E, Biffi A, Delise P, Blomstrom-Lundqvist C, Vanhees L, Ivarhoff P, Dorwarth U, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions, part I: supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil. 2006;13:475- 484.
14. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Circulation. 2008;118:e523- e661.
15. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) [published corrections appear in Circulation. 2005;111:2013-2014; Circulation. 2007;115:e411; and Circulation. 2010;121:e441]. Circulation. 2004;110:e82- e292.
16. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation. 2007;116: 803-877. (Pubitemid 47260464)
17. Heart Failure Society of America; Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1- e194.
18. Bohlen JG, Held JP, Sanderson MO, Patterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med. 1984;144:1745-1748. (Pubitemid 14070024)
19. Chen X, Zhang Q, Tan X. Cardiovascular effects of sexual activity. Indian J Med Res. 2009;130:681- 688.
20. Krüger T, Exton MS, Pawlak C, von zur Mühlen A, Hartmann U, Schedlowski M. Neuroendocrine and cardiovascular response to sexual arousal and orgasm in men. Psychoneuroendocrinology. 1998;23:401-411. (Pubitemid 28355754)
21. Exton MS, Bindert A, Kruger T, Scheller F, Hartmann U, Schedlowski M. Cardiovascular and endocrine alterations after masturbation-induced orgasm in women. Psychosom Med. 1999;61:280-289.
22. Stein RA. Cardiovascular response to sexual activity. Am J Cardiol. 2000;86:27F-29F.
23. Littler WA, Honour AJ, Sleight P. Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil. 1974;40:321-331.
24. Carmichael MS, Warburton VL, Dixen J, Davidson JM. Relationships among cardiovascular, muscular, and oxytocin responses during human sexual activity. Arch Sex Behav. 1994;23:59-79. (Pubitemid 24039953)
25. Exton NG, Truong TC, Exton MS, Wingenfeld SA, Leygraf N, Saller B, Hartmann U, Schedlowski M. Neuroendocrine response to film-induced sexual arousal in men and women. Psychoneuroendocrinology. 2000;25:187-199. (Pubitemid 29525391)
26. Hellerstein HK, Friedman EH. Sexual activity and the postcoronary patient. Arch Intern Med. 1970;125:987-999.
27. Cheitlin MD. Sexual activity and cardiac risk. Am J Cardiol. 2005;96:24M-28M. (Pubitemid 43017213)
28. DeBusk RF. Sexual activity in patients with angina. JAMA. 2003;290:3129-3132. (Pubitemid 37548119)
29. Drory Y. Sexual activity and cardiovascular risk. Eur Heart J Suppl. 2002;4(suppl H):H13-H18. (Pubitemid 35396799)
30. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA. 2011;305:1225-1233.
31. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Tofler GH; Determinants of Myocardial Infarction Onset Study Investigators. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exertion. JAMA. 1996;275:1405-1409. (Pubitemid 26155915)
32. Möller J, Ahlbom A, Hulting J, Diderichsen F, de Faire U, Reuterwall C, Hallqvist J. Sexual activity as a trigger of myocardial infarction: a case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP). Heart. 2001;86:387-390. (Pubitemid 32889371)
33. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med. 1990;322:743-753. (Pubitemid 20092811)
34. Ueno M. The so-called coition death [in Japanese]. Nihon Hoigaku Zasshi. 1963;17:330 -340.
35. Krauland W, Underwarteter T. Herzinfarkt und Sexualität aus der Sicht des Rechtsmediziners [in German]. Sexualmedezin. 1976;10:xx-xxiii.
36. Parzeller M, Raschka C, Bratzke H. Sudden cardiovascular death during sexual intercourse: results of a legal medicine autopsy study [in German]. Z Kardiol. 1999;88:44-48. (Pubitemid 29189677)
37. Paolillo V, Marra S, Chiappa E, Boncompagni F, Oddenino G, Spadaccini F, Angelino PF. Influence of sleep, wakefulness and some daily activities on ventricular ectopic activity in recent myocardial infarction (author's translation) [in Italian]. G Ital Cardiol. 1981;11:12-22. (Pubitemid 11116419)
38. Kavanagh T, Shephard RJ. Sexual activity after myocardial infarction. Can Med Assoc J. 1977;116:1250 -1253.
39. Fries R, König J, Schäfers HJ, Böhm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol. 2002;25:474-478.
40. DeBusk RF, Blomqvist CG, Kouchoukos NT, Luepker RV, Miller HS, Moss AJ, Pollock ML, Reeves TJ, Selvester RH, Stason WB, Wagner GS, Willman VL. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med. 1986;314:161-166. (Pubitemid 16183174)
41. Stein RA. The effect of exercise training on heart rate during coitus in the post myocardial infarction patient. Circulation. 1977;55:738-740. (Pubitemid 8090088)
42. Sable C, Foster E, Uzark K, Bjornsen K, Canobbio MM, Connolly HM, Graham TP, Gurvitz MZ, Kovacs A, Meadows AK, Reid GJ, Reiss JG, Rosenbaum KN, Sagerman PJ, Saidi A, Schonberg R, Shah S, Tong E, Williams RG. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011;123:1454-1485.
43. Papadopoulos C, Shelley SI, Piccolo M, Beaumont C, Barnett L. Sexual activity after coronary bypass surgery. Chest. 1986;90:681-685. (Pubitemid 17181636)
44. Lukkarinen H, Lukkarinen O. Sexual satisfaction among patients after coronary bypass surgery or percutaneous transluminal angioplasty: eight-year follow-up. Heart Lung. 2007;36:262-269. (Pubitemid 47030673)
45. Clark AM, Scott J, Schopflocher D, Myers J, Paterson I, Warburton D, Jones L, Haykowsky M. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on mortality. Eur J Cardiovasc Prev Rehabil. 2011;18(suppl 1):S1. Abstract P111.
46. Bocchi EA, Guimarães G, Mocelin A, Bacal F, Bellotti G, Ramires JF. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation. 2002;106:1097-1103. (Pubitemid 34970850)
47. Freitas D, Athanazio R, Almeida D, Dantas N, Reis F. Sildenafil improves quality of life in men with heart failure and erectile dysfunction. Int J Impot Res. 2006;18:210 -212.
48. Katz SD, Parker JD, Glasser DB, Bank AJ, Sherman N, Wang H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol. 2005;95:36-42. (Pubitemid 40051109)
49. Webster LJ, Michelakis ED, Davis T, Archer SL. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med. 2004;164:514 -520.
50. Rastogi S, Rodriguez JJ, Kapur V, Schwarz ER. Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem. Int J Impot Res. 2005;17(suppl 1):S25-S36. (Pubitemid 43049374)
51. Jaarsma T. Sexual problems in heart failure patients. Eur J Cardiovasc Nurs. 2002;1:61-67. (Pubitemid 36842726)
52. Jaarsma T, Dracup K, Walden J, Stevenson LW. Sexual function in patients with advanced heart failure. Heart Lung. 1996;25:262-270. (Pubitemid 26285023)
53. Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res. 2008;20:85-91.
54. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail. 2000;6:225-232.
55. Steinke EE, Wright DW, Chung ML, Moser DK. Sexual self-concept, anxiety, and self-efficacy predict sexual activity in heart failure and healthy elders. Heart Lung. 2008;37:323-333.
56. Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP; HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial [published correction appears in JAMA. 2009;302:2322]. JAMA. 2009;301:1451-1459.
57. Belardinelli R, Lacalaprice F, Faccenda E, Purcaro A, Perna G. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure. Int J Cardiol. 2005;101:83-90. (Pubitemid 40614740)
58. Steinke EE. Intimacy needs and chronic illness: strategies for sexual counseling and self-management. J Gerontol Nurs. 2005;31:40-50.
59. Bowater SE, Thorne SA. Management of pregnancy in women with acquired and congenital heart disease. Postgrad Med J. 2010;86:100-105.
60. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990 -1996.
61. Vazquez LD, Sears SF, Shea JB, Vazquez PM. Sexual health for patients with an implantable cardioverter defibrillator. Circulation. 2010;122:e465-e467.
62. Steinke EE. Sexual concerns of patients and partners after an implantable cardioverter defibrillator. Dimens Crit Care Nurs. 2003;22:89-96.
63. Mickley H, Petersen J, Nielsen BL. Subjective consequences of permanent pacemaker therapy in patients under the age of retirement. Pacing Clin Electrophysiol. 1989;12:401- 405.
64. Steinke EE, Gill-Hopple K, Valdez D, Wooster M. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung. 2005;34:299 -308.
65. Sears SF, Kovacs AH, Conti JB, Handberg E. Expanding the scope of practice for cardiac rehabilitation: managing patients with implantable cardioverter defibrillators. J Cardiopulm Rehabil. 2004;24:209-215. (Pubitemid 39006599)
66. Vigl M, Kaemmerer M, Seifert-Klauss V, Niggemeyer E, Nagdyman N, Trigas V, Bauer U, Schneider KT, Berger F, Hess J, Kaemmerer H. Contraception in women with congenital heart disease. Am J Cardiol. 2010;106:1317-1321.
67. Vigl M, Hager A, Bauer U, Niggemeyer E, Wittstock B, Köhn FM, Hess J, Kaemmerer H. Sexuality and subjective wellbeing in male patients with congenital heart disease. Heart. 2009;95:1179-1183.
68. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320. (Pubitemid 34250486)
69. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092.
70. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303. (Pubitemid 36119984)
71. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239. (Pubitemid 44789498)
72. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J. 2010;74:2271-2282.
73. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy [published correction appears in Circulation. 2010;122:e7]. Circulation. 2010;121:445- 456.
74. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802-1813. (Pubitemid 30390241)
75. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension: report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet. 1981;2:539-543.
76. Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29(part 1):8-14. (Pubitemid 27078334)
77. Bansal S. Sexual dysfunction in hypertensive men: a critical review of the literature. Hypertension. 1988;12:1-10.
78. Düsing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773-786. (Pubitemid 40593626)
79. Steinke EE, Jaarsma T. Impact of cardiovascular disease on sexuality. In: Moser DK, Riegel B, eds. Cardiac Nursing. St. Louis, MO: Saunders; 2008.
80. Franzen D, Metha A, Seifert N, Braun M, Höpp HW. Effects of beta-blockers on sexual performance in men with coronary heart disease: a prospective, randomized and double blinded study. Int J Impot Res. 2001;13:348 -351.
81. Baumhäkel M, Schlimmer N, Kratz M, Hacket G, Jackson G, Böhm M. Cardiovascular risk, drugs and erectile function: a systematic analysis. Int J Clin Pract. 2011;65:289 -298.
82. Erdmann E. Safety and tolerability of beta-blockers: prejudices & reality. Indian Heart J. 2010;62:132-135.
83. Jackson G, Betteridge J, Dean J, Eardley I, Hall R, Holdright D, Holmes S, Kirby M, Riley A, Sever P. A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement: update 2002. Int J Clin Pract. 2002;56:663- 671.
84. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-357. (Pubitemid 34761614)
85. Silvestri A, Galetta P, Cerquetani E, Marazzi G, Patrizi R, Fini M, Rosano GM. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J. 2003;24:1928 -1932.
86. Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology. 2009;112:174-177.
87. Duncan L, Bateman DN. Sexual function in women: do antihypertensive drugs have an impact? Drug Saf. 1993;8:225-234. (Pubitemid 23123067)
88. Boydak B, Nalbantgil S, Fici F, Nalbantgil I, Zoghi M, Ozerkan F, Tengiz I, Ercan E, Yilmaz H, Yoket U, Onder R. A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men [published correction appears in Clin Drug Investig. 2007;27:864]. Clin Drug Investig. 2005;25:409-416. (Pubitemid 41019988)
89. Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34:327-331.
90. Olsson AM, Persson CA; Swedish Sildenafil Investigators Group. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease. Int J Clin Pract. 2001;55:171-176. (Pubitemid 32390154)
91. Kloner RA. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation. 2004;110:3149 -3155.
92. Morales AM, Mirone V, Dean J, Costa P. Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging. 2009;4:463- 472.
93. Kloner RA, Brown M, Prisant LM, Collins M; Sildenafil Study Group. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Am J Hypertens. 2001;14:70 -73.
94. Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol. 2003;92:47M-57M. (Pubitemid 37386275)
95. Padma-Nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60(suppl 2):67-90. (Pubitemid 35303364)
96. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, Stein RA, Larkin S, Mazzu A, Tota R, Pomerantz K, Sundaresan P. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002;40:2006 -2012.
97. Arruda-Olson AM, Mahoney DW, Nehra A, Leckel M, Pellikka PA. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA. 2002;287:719 -725.
98. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM; Technology and Practice Executive Committee. Use of sildenafil (Viagra) in patients with cardiovascular disease [published correction appears in Circulation. 1999;100:2389]. Circulation. 1999;99:168-177. (Pubitemid 29035976)
99. Mittleman MA, Maclure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. Am J Cardiol. 2005;96:443- 446.
100. Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, Mancia G. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens. 2004;17(part 1):1135-1142. (Pubitemid 40029411)
101. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease [published correction appears in Am J Cardiol. 2004;94:543-544]. Am J Cardiol. 2004;93:147-153. (Pubitemid 38058721)
102. Fox KM, Thadani U, Ma PT, Nash SD, Keating Z, Czorniak MA, Gillies H, Keltai M; CAESAR I (Clinical American and European Studies of Angina and Revascularization) Investigators. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003;24:2206-2212. (Pubitemid 37522673)
103. Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM. Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol. 2006;97:1778-1784. (Pubitemid 43833438)
104. Van AH, Zumbé J, Stauch K, Hanisch JU. The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with erectile dysfunction and cardiovascular or metabolic conditions. J Sex Med. 2010;7:3161-3169.
105. Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin. 2007;23:2453-2460. (Pubitemid 350033447)
106. Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F, Wong DG, Ahuja S. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US [published correction appears in J Sex Med. 2007;4:522]. J Sex Med. 2007;4:166-175. (Pubitemid 46002379)
107. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol. 1999;83:21C-28C. (Pubitemid 29122754)
108. Kloner RA, Hutter AM, Emmick JT, Mitchell MI, Denne J, Jackson G. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42:1855-1860. (Pubitemid 37433669)
109. Kloner R. Erectile dysfunction and hypertension. Int J Impot Res. 2007;19:296-302. (Pubitemid 46701457)
110. Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, Warner MR, Pereira A. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004;172(part 1):1935-1940. (Pubitemid 39363095)
111. Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med. 2010;7(part 2):858-872.
112. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E; Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605- 613.
113. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333. (Pubitemid 34761611)
114. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712. (Pubitemid 38489892)
115. Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan MA, Kitchener H, McNamee R, Elstein M, Kay C, Seif M, Buckley H; ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002;360:2001-2008. (Pubitemid 36026578)
116. Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P. Vaginal oestrogen therapy after breast cancer: is it safe? Eur J Cancer. 2005;41:2673-2681. (Pubitemid 41607558)
117. Savaliya AA, Shah RP, Prasad B, Singh S. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF. J Pharm Biomed Anal. 2010;52:406-409.
118. Oh SS, Zou P, Low MY, Koh HL. Detection of sildenafil analogues in herbal products for erectile dysfunction. J Toxicol Environ Health A. 2006;69:1951-1958. (Pubitemid 44423273)
119. Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010;44:1022-1029.
120. Aoki H, Nagao J, Ueda T, Strong JM, Schonlau F, Yu-Jing S, Lu Y, Horie S. Clinical assessment of a supplement of Pycnogenol and l-arginine in Japanese patients with mild to moderate erectile dysfunction. Phytother Res. May 27, 2011. doi:10.1002/ptr.3462. http://onlinelibrary.wiley.com/doi/10.1002/ptr.3462/ abstract. Accessed May 27, 2011.
121. Musso NR, Vergassola C, Pende A, Lotti G. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens. 1995;8:565-571.
122. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58-64. (Pubitemid 43042690)
123. Moser DK, Dracup K, Evangelista LS, Zambroski CH, Lennie TA, Chung ML, Doering LV, Westlake C, Heo S. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung. 2010;39:378 -385.
124. Roose SP, Seidman SN. Sexual activity and cardiac risk: is depression a contributing factor? Am J Cardiol. 2000;86:38F- 40F.
125. Mosack V, Steinke EE. Trends in sexual concerns after myocardial infarction. J Cardiovasc Nurs. 2009;24:162-170.
126. Lai YH, Hsieh SR, Ho WC, Chiou AF. Factors associated with sexual quality of life in patients before and after coronary artery bypass grafting surgery. J Cardiovasc Nurs. 2011;26:487-496.
127. Phan A, Ishak WW, Shen BJ, Fuess J, Philip K, Bresee C, Czer L, Schwarz ER. Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med. 2010;7:2765-2773.
128. Kazemi-Saleh D, Pishgou B, Assari S, Tavallaii SA. Fear of sexual intercourse in patients with coronary artery disease: a pilot study of associated morbidity. J Sex Med. 2007;4:1619-1625. (Pubitemid 47616852)
129. Nicolosi A, Moreira ED Jr, Villa M, Glasser DB. A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men. J Affect Disord. 2004;82:235-243. (Pubitemid 39370825)
130. Steinke EE, Swan JH. Effectiveness of a videotape for sexual counseling after myocardial infarction. Res Nurs Health. 2004;27:269-280. (Pubitemid 39221026)
131. Klein R, Bar-on E, Klein J, Benbenishty R. The impact of sexual therapy on patients after cardiac events participating in a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil. 2007;14:672-678. (Pubitemid 47556405)
132. Steinke EE, Wright DW. The role of sexual satisfaction, age, and cardiac risk factors in the reduction of post-MI anxiety. Eur J Cardiovasc Nurs. 2006;5:190-196. (Pubitemid 44176414)
133. Froelicher ES, Kee LL, Newton KM, Lindskog B, Livingston M. Return to work, sexual activity, and other activities after acute myocardial infarction.
134. Dhabuwala CB, Kumar A, Pierce JM. Myocardial infarction and its influence on male sexual function. Arch Sex Behav. 1986;15:499-504. (Pubitemid 17226950)
135. Jaarsma T, Strömberg A, Fridlund B, De Geest S, Mårtensson J, Moons P, Norekval TM, Smith K, Steinke E, Thompson DR; UNITE Research Group. Sexual counselling of cardiac patients: nurses' perception of practice, responsibility and confidence. Eur J Cardiovasc Nurs. 2010;9:24-29.
136. Steinke EE, Patterson-Midgley P. Sexual counseling of MI patients: nurses' comfort, responsibility, and practice. Dimens Crit Care Nurs. 1996;15:216 -223.
137. Vassiliadou A, Stamatopoulou E, Triantafyllou G, Gerodimou E, Toulia G, Pistolas D. The role of nurses in the sexual counseling of patients after myocardial infarction. Health Sci J. 2008;2:111-118.
138. Steinke EE, Mosack V, Barnason S, Wright DW. Progress in sexual counseling by cardiac nurses, 1994 to 2009. Heart Lung. 2011;40:e15-e24.
139. Bedell SE, Duperval M, Goldberg R. Cardiologists' discussions about sexuality with patients with chronic coronary artery disease. Am Heart J. 2002;144:239-242. (Pubitemid 34879646)
140. Steinke E, Patterson-Midgley P. Sexual counseling following acute myocardial infarction. Clin Nurs Res. 1996;5:462-472. (Pubitemid 126737472)
141. Steinke EE, Patterson-Midgley P. Importance and timing of sexual counseling after myocardial infarction. J Cardiopulm Rehabil. 1998;18:401-407. (Pubitemid 29024887)
142. Akdolun N, Terakye G. Sexual problems before and after myocardial infarction: patients' needs for information. Rehabil Nurs. 2001;26:152-158.
143. Arenhall E, Kristofferzon ML, Fridlund B, Nilsson U. The female partners' experiences of intimate relationship after a first myocardial infarction. J Clin Nurs. 2011;20:1677-1684.
144. Arenhall E, Kristofferzon ML, Fridlund B, Malm D, Nilsson U. The male partners' experiences of the intimate relationships after a first myocardial infarction. Eur J Cardiovasc Nurs. 2011;10:108-114.
145. Ivarsson B, Fridlund B, Sjöberg T. Information from health care professionals about sexual function and coexistence after myocardial infarction: a Swedish national study. Heart Lung. 2009;38:330-335.
146. Hardin SR. Cardiac disease and sexuality: implications for research and practice. Nurs Clin North Am. 2007;42:593-603.
147. Jaarsma T, Steinke EE, Gianotten WL. Sexual problems in cardiac patients: how to assess, when to refer. J Cardiovasc Nurs. 2010;25:159-164.
148. Steinke EE, Mosack V, Wright DW, Chung ML, Moser DK. Risk factors as predictors of sexual activity in heart failure. Dimens Crit Care Nurs. 2009;28:123-129.